Researcher Contact
Christophe Bernard
Directeur de recherche Inserm
Unité mixte Inserm 1106 « Institut de neurosciences des systèmes » (Marseille)
+ 33 (0) 4 91 29 98 06 / 06 18 04 49 13
puevfgbcur.oreaneq@havi-nzh.se
The European Food Safety Authority (EFSA) has just announced that consumption of more than 400 milligrams of caffeine per day (i.e. 4 espressos) may be harmful for health. Caffeine consumed in high doses may be involved in cardiovascular disorders and problems of the nervous system (sleep, anxiety, etc.).
Below this threshold of 400 mg per day, there is no risk to adults from coffee.
Furthermore, for pregnant women and children, the recommended limit is reduced to 200 mg per day and 3 mg/kg, respectively.
In 2014, Christophe Bernard, Inserm Research Director, and his team first described the harmful effects of coffee consumption during pregnancy on the brains of mouse progeny. [1]
Throughout the year, this team from Inserm Unit 1106, “Institute of Systems Neuroscience,” works to investigate the role of caffeine in the development of metabolic and brain diseases.
[1] See the press release “Caffeine consumption during pregnancy and its effects on the brain during development” on the Inserm press office website.
Christophe Bernard
Directeur de recherche Inserm
Unité mixte Inserm 1106 « Institut de neurosciences des systèmes » (Marseille)
+ 33 (0) 4 91 29 98 06 / 06 18 04 49 13
puevfgbcur.oreaneq@havi-nzh.se
Scientific Opinion on the safety of caffeine
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) European Food Safety Authority (EFSA), Parma, Italy
EFSA Journal, 27 mai 2015